FDA issues warning on fraudulent drug product, purporting to be the injectable cancer treatment

The Wall Street Journal (2/6, Weaver, Subscription Publication) reports that the FDA on Tuesday, issued a warning to healthcare providers that a fraudulent drug product, purporting to be the injectable cancer treatment, Altuzan (bevacizumab), is being distributed in the US. The agency said the Great Neck, New York-based drug wholesaler, Pharmalogical, shipped two batches of Altuzan, the Turkish brand name for Roche Holding's Avastin, to providers in the US; and internal laboratory tests so far, have confirmed that there is no active ingredient in at least one of the batches. The FDA said that although it is not aware of any patients having received the fraudulent product, the agency is still working to identify physicians who may have purchased the product from Pharmalogical, which also does business under the names Medical Device King and Taranis Medical. Meanwhile, the Journal says an attorney representing Pharmalogical is claiming the FDA's warning is inaccurate.

from DIA Daily

DIA Daily. This daily enewsletter features summaries of breaking news and information about the pharmaceutical, biotechnology, and medical device fields from thousands of global news sources. This easy-to-read enewsletter is delivered to your inbox every business morning.

Subscribe to the DIA Daily.
View archives.
iPhone and iPad Apps available! Download "BulletinHC."DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.

If you would like more information about, or have a question pertaining to, DIA Membership and its benefits, please email membership@diahome.org.Click here to check your membership status.

Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191